https://doi.org/10.4081/monaldi.2021.1736
Operational research as an instrument to address the critical gaps for effective treatment of tuberculosis in eastern Europe and central Asia
Published: January 14, 2021
Abstract Views: 855
PDF: 512
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Editorial
Global tuberculosis report 2020. Geneva: World Health Organization; 2020 (https://apps.who.int/iris/handle/10665/336069).
Coronavirus Disease (COVID-19) Dashboard. Geneva: World Health Organization; 2020 [website] (https://covid19.who.int/).
Clinical management of COVID-19: interim guidance, 27 May 2020. Geneva: World Health Organization; 2020 (https://apps.who.int/iris/handle/10665/332196).
Dara M, Sotgiu G, Reichler M R. et al. New diseases and old threats: lessons from tuberculosis for the COVID-19 response. Int J Tubercul Lung Dis 2020;24;544-5.
United Nations Sustainable Development. Transforming our world: the 2030 Agenda for Sustainable Development. 2014 [website] (https://sustainabledevelopment.un.org/post2015/transformingourworld).
WHO Regional Office for Europe, European Centre for Disease Prevention and Control. Tuberculosis surveillance and monitoring in Europe 2020–2018 data. Copenhagen, Stockholm: WHO Regional Office for Europe and European Centre for Disease Prevention and Control; 2020 (https://apps.who.int/iris/handle/10665/331530).
Dadu A, Hovhannesyan A, Ahmedov S, et al. Drug-resistant tuberculosis in eastern Europe and central Asia: a time-series analysis of routine surveillance data. Lancet Infect Dis 2019;20:250-8.
The end TB Strategy. Geneva: World Health Organization; 2015 (https://apps.who.int/iris/handle/10665/331326).
Moscow Declaration to End TB. Geneva: World Health Organization; 2017. (https://www.who.int/tb/features_archive/Moscow_Declaration_to_End_TB_final_ENGLISH.pdf?ua=1).
Global Strategy for Tuberculosis Research and Innovation. Geneva: World Health Organization; 2020 (https://apps.who.int/iris/handle/10665/336076).
Process Overview: Development of a Global Strategy for TB Research and Innovation. World Health Organization; 2020[website] (https://www.who.int/tb/features_archive/Process-Global-strategy-for-TB-research-innovation/en/).
Member States adopt the Global Strategy for TB Research and Innovation at 73rd World Health Assembly [website]. World Health Organization; 2020. (https://www.who.int/news/item/10-08-2020-member-states-adopt-the-global-strategy-for-tb-research-and-innovation-at-73rd-world-health-assembly#:~:text=World%20Health%20Assembly-).
The WHO strategy on research for health. Geneva: World Health Organization; 2012. (https://apps.who.int/iris/handle/10665/77935).
WHO Regional Office for Europe. Evidence-informed policymaking. Copenhagen: WHO Regional Office for Europe; 2020 (https://www.euro.who.int/en/data-and-evidence/evidenceinformed-policy-making/evidence-informed-policy-making).
European Programme of Work, 2020–2025 – “United Action for Better Health in Europeâ€. 70th session of the Regional Committee for Europe. Copenhagen: WHO Regional Office for Europe; 2020 (Document: EUR/RC70/11 Rev.4; https://www.euro.who.int/en/about-us/governance/regional-committee-foreurope/70th-session/documentation/working-documents/eurrc7011-rev.4-european-programme-of-work-20202025-unitedaction-for-better-health-in-europe).
Structured operational research training of the European Tuberculosis Research Initiative: workshops 1 and 2 of 4 [website]. Copenhagen: WHO Regional Office for Europe; 2018. (https://www.euro.who.int/en/media-centre/events/events/2018/10/structured-operational-research-training-of-the-europeantuberculosis-rsearch-initiative-workshops-1-and-2-of-4).
Defining the tuberculosis research agenda for the WHO European Region: a study report of the European TB Research Initiative. Copenhagen: WHO Regional Office for Europe; 2019 (https://apps.who.int/iris/handle/10665/327085).
Tuberculosis and drug-resistant tuberculosis in eastern Europe: operational research from the SORT IT Programme, 2012–2014. Public Health Action 2014;4 (Suppl 2) [website]. Copenhagen: WHO Regional Office for Europe; 2014 (https://www.euro.who.int/en/health-topics/communicable-diseases/tuberculosis/news/news/2014/10/supplement-tuberculosis-and-drug-resistant-tuberculosis-in-eastern-europe-operational-research-from-the-sort-it-programme,-20122014-just-published).
Gogichadze N, Kuchukhidze G, Merabishvili T, Tsereteli M. et al. Poor follow-up of paediatric tuberculosis contacts in Tbilisi, Georgia. Public Health Panorama 2019;5:447-51 (https://apps.who.int/iris/handle/10665/330190).
Kabasakalyan E, Davtyan K, et al. A cross-sectional study of the turnaround time of Armenia’s national tuberculosis programme laboratory services in 2017–2018. Public Health Panorama 2019;5:459-66 (https://apps.who.int/iris/handle/10665/330192).
Korotych O, Hovhannisyan A, et al. Risk factors associated with MDR/RR-TB among new pulmonary tuberculosis patients in urban and rural areas of Ukraine in 2017: retrospective analysis of routine surveillance data. Public Health Panorama 2019;5:536-47 (https://apps.who.int/iris/handle/10665/330200).
Kabasakalyan E, Khachatryan A, et al. Underreporting of diagnosed tuberculosis cases to the national surveillance system in Armenia in 2017. Public Health Panorama 2019;5:476-83 (https://apps.who.int/iris/handle/10665/330194) .
A people-centred model of TB care: Blueprint for EECA countries, first edition. Copenhagen: WHO Regional Office for Europe; 2017. (https://www.euro.who.int/__data/assets/pdf_file/0004/342373/TB_Content_WHO_PRO_eng_final.pdf).
WHO Consolidated Guidelines on Tuberculosis, Module 4: Treatment - Drug-Resistant Tuberculosis Treatment. Geneva: World Health Organization; 2020 (https://apps.who.int/iris/handle/10665/332397).
Ciobanu A, Plesca V, et al. Assessment of multidrug- resistant tuberculosis associated catastrophic costs incurred by families/households in the Republic of Moldova. 2017 (project report). (https://www.researchgate.net/pub- lication/321051278_Assessment_of_multidrug-resistant_tuber- culosis_associated_catastrophic_costs_incurred_by_fami- lieshouseholds_in_the_Republic_of_Moldova).
Duko B, Bedaso A, Ayano G. The prevalence of depression among patients with tuberculosis: A systematic review and metaanalysis. Ann Gen Psychiatry 2020;19:30 (https://annals-generalpsychiatry.biomedcentral.com/articles/10.1186/s12991-020-00281-8).
Psychosocial support for people with TB, HIV and viral hepatitis in the continuum of care in the WHO European Region: Report, July 2020. Copenhagen: WHO Regional Office for Europe; 2020 (https://www.euro.who.int/en/health-topics/communicable-diseases/tuberculosis/publications/2020/psychosocial-support-forpeople-with-tb,-hiv-and-viral-hepatitis-in-the-continuum-ofcare-in-the-who-european-region.-report-july-2020).
Borisov S, Danila E, Maryandyshev A, et al. Surveillance of adverse events in the treatment of drug-resistant tuberculosis: First global report. Eur Respir J 2019;54:1901522.
How to Cite
Korotych, Oleksandr, Andrei Dadu, Askar Yedilbayev, and Masoud Dara. 2021. “Operational Research As an Instrument to Address the Critical Gaps for Effective Treatment of Tuberculosis in Eastern Europe and Central Asia”. Monaldi Archives for Chest Disease 91 (1). https://doi.org/10.4081/monaldi.2021.1736.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Lilit Khachatryan, Ruzanna Grigoryan, Andrei Dadu, Ajay M.V. Kumar, Kristina Akopyan, Kostyantyn Dumchev, Hasmik Harutyunyan, Alberto Matteelli, Factors associated with unfavourable treatment outcomes among people with rifampicin-resistant tuberculosis in Armenia, 2014-2017 , Monaldi Archives for Chest Disease: Vol. 91 No. 1 (2021)
- H. Sumikawa, T. Johkoh, N. Tomiyama, S. Hamada, M. Koyama, M. Tsubamoto, S. Murai, A. Inoue, H. Nakamura, T. Tachibana, N.L. Müller, Pulmonary Alveolar Microlithiasis: CT and pathologic findings in 10 patients , Monaldi Archives for Chest Disease: Vol. 63 No. 1 (2005): Pulmonary series
- Varvara Solodovnikova, Ajay M.V. Kumar, Hennadz Hurevich, Yuliia Sereda, Vera Auchynka, Dzmitry Katovich, Dzmitry Klimuk, Aliaksandr Skrahin, Svetlana Setkina, Iryna Charnysh, Askar Yedilbayev, Alena Skrahina, Effectiveness and safety of delamanid- or bedaquiline-containing regimens among children and adolescents with multidrug resistant or extensively drug resistant tuberculosis: A nationwide study from Belarus, 2015-19 , Monaldi Archives for Chest Disease: Vol. 91 No. 1 (2021)
- Marinella Sommaruga, Elisabetta Angelino, Paola Della Porta, Mara Abatello, Giacomo Baiardo, Gianluigi Balestroni, Ornella Bettinardi, Edward Callus, Chiara Ciracì, Ombretta Omodeo, Claudia Rizza, Paolo Michielin, Marco Ambrosetti, Raffaele Griffo, Roberto F.E. Pedretti, Antonia Pierobon, Best practice in psychological activities in cardiovascular prevention and rehabilitation: Position Paper , Monaldi Archives for Chest Disease: Vol. 88 No. 2 (2018)
- M. Bugiani, S. Bonora, A. Carosso, P. Piccioni, M. Cavallero, A. Mondo, V. Ghisetti, The effect of antituberculosis treatment on interferon-γ release assay results , Monaldi Archives for Chest Disease: Vol. 75 No. 4 (2011): Pulmonary series
- Luca Degli Esposti, Diego Sangiorgi, Marcello Arca, Giovanni B. Vigna, Stefano Buda, Ezio Degli Esposti, Achievement of therapeutic target in subjects on statin treatment in clinical practice. Results of the STAR (Statins Target Assessment in Real practice) study , Monaldi Archives for Chest Disease: Vol. 76 No. 4 (2011): Cardiac series
- Kiran B, Rupak Singla, Neeta Singla, Vinay V, Kuljeet Singh, Madhumita Paul Choudhury, Nilotpal Bhattacherjee, Factors affecting the treatment outcome of injection based shorter MDR-TB regimen at a referral centre in India , Monaldi Archives for Chest Disease: Vol. 93 No. 3 (2023)
- Seyed Jalal Hashemi, Seyed Ali Javad Moosavi, Esmaeil Idani, Ali Javaherforoushzadeh, Hanieh Raji, Association of esophageal dilatation in chest CT scan with gastroesophageal reflux disease: A case control study , Monaldi Archives for Chest Disease: Vol. 88 No. 2 (2018)
- Yeliz Akturk, Serra Ozbal Günes, Baki Hekimoglu, A rib abnormality mimicking pulmonary nodule: a pitfall in the plain chest x-ray , Monaldi Archives for Chest Disease: Vol. 81 No. 1-2 (2015): Pulmonary series
- Mariana Buziashvili, Hayk Davtyan, Yuliia Sereda, Olga Denisiuk, Ogtay Gozalov, Nino Lomtadze, Arax Hovhannesyan, Incidence rate and time to serious adverse events among rifampicin resistant tuberculosis patients in Georgia treated with new and repurposed anti-tuberculosis drugs, 2016-2018 , Monaldi Archives for Chest Disease: Vol. 91 No. 1 (2021)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
You may also start an advanced similarity search for this article.
